Terms: = Lung cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Diagnosis
15 results:
1. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
2. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological characteristics of primary peritoneal epithelioid mesothelioma of clear cell type: A case report.
Du XM; Wei YP; Gao Y; Li Z; Zhang JM; Chang H; Li Y
Medicine (Baltimore); 2021 Mar; 100(12):e25264. PubMed ID: 33761726
[TBL] [Abstract] [Full Text] [Related]
4. Combination of Immunomagnetic Separation with Aptamer-Mediated Double Rolling Circle Amplification for Highly Sensitive Circulating Tumor Cell Detection.
Sun S; Yang S; Hu X; Zheng C; Song H; Wang L; Shen Z; Wu ZS
ACS Sens; 2020 Dec; 5(12):3870-3878. PubMed ID: 33205648
[TBL] [Abstract] [Full Text] [Related]
5. Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing.
Zhao Y; He JY; Cui JZ; Meng ZQ; Zou YL; Guo XS; Chen X; Wang X; Yan LT; Han WX; Li C; Guo L; Bu H
BMC Cancer; 2020 Jul; 20(1):690. PubMed ID: 32711494
[TBL] [Abstract] [Full Text] [Related]
6. Frequency of Germline Mutations in cancer Susceptibility Genes in Malignant Mesothelioma.
Panou V; Gadiraju M; Wolin A; Weipert CM; Skarda E; Husain AN; Patel JD; Rose B; Zhang SR; Weatherly M; Nelakuditi V; Knight Johnson A; Helgeson M; Fischer D; Desai A; Sulai N; Ritterhouse L; Røe OD; Turaga KK; Huo D; Segal J; Kadri S; Li Z; Kindler HL; Churpek JE
J Clin Oncol; 2018 Oct; 36(28):2863-2871. PubMed ID: 30113886
[TBL] [Abstract] [Full Text] [Related]
7. A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia.
Foxler DE; Bridge KS; Foster JG; Grevitt P; Curry S; Shah KM; Davidson KM; Nagano A; Gadaleta E; Rhys HI; Kennedy PT; Hermida MA; Chang TY; Shaw PE; Reynolds LE; McKay TR; Wang HW; Ribeiro PS; Plevin MJ; Lagos D; Lemoine NR; Rajan P; Graham TA; Chelala C; Hodivala-Dilke KM; Spendlove I; Sharp TV
EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29930174
[TBL] [Abstract] [Full Text] [Related]
8. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.
Andrade MO; Cunha VSD; Oliveira DC; Moraes OL; Lofrano-Porto A
Arch Endocrinol Metab; 2018; 62(2):264-269. PubMed ID: 29768630
[TBL] [Abstract] [Full Text] [Related]
9. Independent association of PD-L1 expression with noninactivated vhl clear cell renal cell carcinoma-A finding with therapeutic potential.
Kammerer-Jacquet SF; Crouzet L; Brunot A; Dagher J; Pladys A; Edeline J; Laguerre B; Peyronnet B; Mathieu R; Verhoest G; Patard JJ; Lespagnol A; Mosser J; Denis M; Messai Y; Gad-Lapiteau S; Chouaib S; Belaud-Rotureau MA; Bensalah K; Rioux-Leclercq N
Int J Cancer; 2017 Jan; 140(1):142-148. PubMed ID: 27623354
[TBL] [Abstract] [Full Text] [Related]
10. Somatic and germline mutations in NETs: Implications for their diagnosis and management.
Minnetti M; Grossman A
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):115-27. PubMed ID: 26971848
[TBL] [Abstract] [Full Text] [Related]
11. Clinical utility of determining tumor markers in patients with signs and symptoms of cancer.
Trapé J; Sala M; Franquesa F; Ordeig JM; Soler-Bel JM; Bustamante E; Pérez R; Aligué J; Montesinos J; Arnau A; Ordeig-Villanueva R
Clin Chem Lab Med; 2015 Feb; 53(3):485-91. PubMed ID: 25274947
[TBL] [Abstract] [Full Text] [Related]
12. Hemangioblastoma-like clear cell stromal tumor of the lung.
Falconieri G; Mirra M; Michal M; Suster S
Adv Anat Pathol; 2013 Mar; 20(2):130-5. PubMed ID: 23399799
[TBL] [Abstract] [Full Text] [Related]
13. [The current clinical status of kidney cancers in patients with the vhl disease in Japan: a nationwide epidemiological survey].
Shuin T; Shinohara N; Yao M; Yamasaki I; Tamura K; Kamada M
Nihon Hinyokika Gakkai Zasshi; 2012 May; 103(3):552-6. PubMed ID: 22876660
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
Kitano M; Millo C; Rahbari R; Herscovitch P; Gesuwan K; Webb RC; Venkatesan AM; Phan GQ; Hughes MS; Libutti SK; Nilubol N; Linehan WM; Kebebew E
Surgery; 2011 Dec; 150(6):1122-8. PubMed ID: 22136831
[TBL] [Abstract] [Full Text] [Related]
15. [The von Hippel-Lindau syndrome with pheochromocytoma].
Palmar I; Vircburger M; Manojlović D; Radević B; Andjelković Z; Burić B; Savicević M; Nesković G
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():43-6. PubMed ID: 12584997
[TBL] [Abstract] [Full Text] [Related]
